We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.85 | 4.70 | 5.00 | 4.85 | 4.85 | 4.85 | 31,922 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -11.55 | 25.87M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/10/2019 11:52 | Jaknife, by all means. And will you undertake to the same...? | brucie5 | |
17/10/2019 07:39 | Shinny new website from Eden that nicely contradicts the 'Eden is primarily a Crop protection company' narrative and reminds us of what Cenkos were told to exclude. A new refreshed TT/Bayer section with details of what's in the pipeline once they resolve and improve all the Formulation / IP issues currently creating the Parallel delays. | supersonico | |
16/10/2019 23:04 | Also the man who say 2p. | monet | |
16/10/2019 16:44 | Says the sensible man who can't say Cedroz..LOL | supersonico | |
16/10/2019 16:28 | Paulpaola Thanks for your advice but I'll be carrying on doing what I do..some of which you like and some of which you won't. The idea that posters like Fraudy are 'good to challenge our thinking' just shows a staggering level of ignorance and naivety about the nature of that 'challenge' , it's motives and methods. | supersonico | |
16/10/2019 13:21 | Sean CEO has just bought 114,313 see RNS. Please stop this confusing talk of fraud and luby, nobody else understands who or what you are talking about. Most of your posts super and full of good references and facts. The best of all Eden posts. Those are the ones I like. Negative posters like Jak are good to challenge our thinking. I welcome them. | paulpaolo | |
16/10/2019 12:20 | Fraudy as a Buyer is the only way to make sense of his Lemonism. Looks like the other SS not convinced by Fraudy Lemonism either. | supersonico | |
16/10/2019 11:57 | Bottom achieved? Maybe some further testing of investors' nerves before the full bounce back. Time for Jak to see if he can mop up some more shares, or close his shorts . ;) | brucie5 | |
16/10/2019 10:05 | Good to See Mr51K back..that will please Northwick:) | supersonico | |
16/10/2019 08:42 | Well Done Eden/Eastman on Belgian Cedroz approval. Home of Taminco who Eastman bought in 2014..Doesn't time fly.. I'm still not convinced these approvals are not being managed ..I'll wait until I see a big one before I change my mind on that. …... Interesting how Eden are describing their market, particularly the relatively new 'plastic free' addition and potentially made more commercially valuable by further regulatory pressure in this area that inevitably will follow on from the ECHA public consultation. What is also of note to this amateur sleuth is that it's much easier to find references to micro plastics/beads in Personal care products than pesticide formulation literature. That's interesting because of the incongruence in the Eden what we say we're doing to what we are actually doing narrative and the loss of 3/4 plus of TT etc. 'Eden Research plc (AIM: EDEN), the AIM listed company that develops and supplies breakthrough biopesticide products and natural, plastic-free microencapsulation technologies to the global crop protection, animal health and consumer products industries, is pleased....' 'Every week, we ingest the plastic equivalent of a bank card! Did you know that?' | supersonico | |
15/10/2019 23:51 | Says the man who can't say Cedroz..and predicted 2p by xmas 2017. yaaaaaaawwwwwwwwwwww | supersonico | |
15/10/2019 19:21 | Badger, if you reread the commentary they mentioned 300k of rev, I think, which just missed the H1. Make of that what you will. | brucie5 | |
15/10/2019 19:01 | I would not base my share purchase on Mevalone sales.. with revenues up or down. If you are then I would keep out of Eden until you have fully researched the bigger picture. | supersonico | |
15/10/2019 18:17 | I'm considering buying Eden shares because of the exciting technology and pipeline. The current low price of 8p is tempting but I'm concerned that sales for the six months ended 30 June 2019 were down to £0.45m from £0.68m in the first 6 months of 2018. Why did sales fall instead of rise? | bluebadger | |
15/10/2019 06:17 | Most likely the case Investing. | supersonico | |
14/10/2019 23:35 | Super, If there is a willing buyer anywhere, I am sure there are plenty of available shares for them to have as I would imagine a number of people will be willing to cash out, albeit at a higher price than today. | investingisatrickygame | |
14/10/2019 13:33 | More for Mrs100k and Chase etal :) | supersonico | |
14/10/2019 13:09 | I'm pretty certain NY will not be buying any more shares. | investingisatrickygame | |
14/10/2019 10:03 | Likely speaking too soon but.. It looks to me like Country approvals for Mev/Ced being managed and joining the TT/BAYER/SustainE / Parallel delayed formation squadron . Looks like their is a plan. I'm expecting more buying from New York etal while we are in this holding pattern. | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions